Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model
Authors
Keywords
CXCR4, CXCL12, Glioma, Plerixafor, Microglia, Macrophage polarization, Tumor microenvironment, GAM
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 35, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-25
DOI
10.1186/s13046-016-0326-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of microglia and macrophages in glioma maintenance and progression
- (2016) Dolores Hambardzumyan et al. NATURE NEUROSCIENCE
- Cancer cell metabolism and the modulating effects of nitric oxide
- (2015) Ching-Fang Chang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Understanding Local Macrophage Phenotypes In Disease: Modulating macrophage function to treat cancer
- (2015) Vincenzo Bronte et al. NATURE MEDICINE
- Glioma-Associated Microglia/Macrophages Display an Expression Profile Different from M1 and M2 Polarization and Highly Express Gpnmb and Spp1
- (2015) Frank Szulzewsky et al. PLoS One
- Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway
- (2015) Emeline Tabouret et al. Oncotarget
- The role of CXCR4 in highly malignant human gliomas biology: Current knowledge and future directions
- (2014) Filippo Gagliardi et al. GLIA
- CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells
- (2014) C Ieranò et al. Cell Death & Disease
- Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9
- (2013) E. Zajac et al. BLOOD
- Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia
- (2013) Aleksandra Ellert-Miklaszewska et al. GLIA
- Glioblastoma and Other Malignant Gliomas
- (2013) Antonio Omuro JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cytokine Patterns in Brain Tumour Progression
- (2013) Radu Albulescu et al. MEDIATORS OF INFLAMMATION
- Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats
- (2013) Shie-Chau Liu et al. NEURO-ONCOLOGY
- CXCR4 and CXCR7 form a functional receptor unit for SDF-1/CXCL12 in primary rodent microglia
- (2013) J. Lipfert et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases
- (2013) Luigi Portella et al. PLoS One
- Radiation Therapy-Induced Tumor Invasiveness Is Associated with SDF-1-Regulated Macrophage Mobilization and Vasculogenesis
- (2013) Shu-Chi Wang et al. PLoS One
- Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity
- (2013) Monica Gatti et al. TOXICOLOGY
- Immune Surveillance Properties of Human NK Cell-Derived Exosomes
- (2012) L. Lugini et al. JOURNAL OF IMMUNOLOGY
- The molecular profile of microglia under the influence of glioma
- (2012) W. Li et al. NEURO-ONCOLOGY
- CXCR4 Expression Predicts Patient Outcome and Recurrence Patterns after Hepatic Resection for Colorectal Liver Metastases
- (2011) Adam C. Yopp et al. ANNALS OF SURGICAL ONCOLOGY
- Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas
- (2011) D Tseng et al. BRITISH JOURNAL OF CANCER
- The brain tumor microenvironment
- (2011) Nikki A. Charles et al. GLIA
- Characteristics of the Alternative Phenotype of Microglia/Macrophages and its Modulation in Experimental Gliomas
- (2011) Konrad Gabrusiewicz et al. PLoS One
- CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
- (2010) B. A. Teicher et al. CLINICAL CANCER RESEARCH
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
- (2010) Mitomu Kioi et al. JOURNAL OF CLINICAL INVESTIGATION
- Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1 , CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer
- (2009) L. Xu et al. CANCER RESEARCH
- AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
- (2009) I. Kalatskaya et al. MOLECULAR PHARMACOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now